Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study

Abstract

Stereotactic ablative body radiation (SABR) delivers high rates of local control in early-stage non-small cell lung cancer (NSCLC); however, systemic immune effects are poorly understood. Here, we evaluate the early...